Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Aurinia Renal Response in Active Lupus With Voclosporin

ClinicalTrials.gov ID: NCT03021499

Public ClinicalTrials.gov record NCT03021499. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 4:33 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg Twice Daily) With Placebo in Achieving Renal Response in Subjects With Active Lupus Nephritis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to assess the efficacy of voclosporin compared with placebo in achieving renal response after 52 weeks of therapy in subjects with active lupus nephritis.

Study identification

NCT ID
NCT03021499
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Aurinia Pharmaceuticals Inc.
Industry
Enrollment
358 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 17, 2017 (Actual)
Primary completion
Sep 24, 2019 (Actual)
Completion
Oct 10, 2019 (Actual)
Last update posted
Mar 27, 2023

2017 – 2019

United States locations

U.S. sites
59
U.S. states
24
U.S. cities
50
Facility City State ZIP Site status
AURORA Investigative Center Huntsville Alabama 35805 —
AURORA Investigative Center Phoenix Arizona 85032 —
AURORA Investigative Center Phoenix Arizona 85037 —
AURORA Investigative Center Beverly Hills California 90211 —
AURORA Investigative Center Los Angeles California 90022 —
AURORA Investigative Center Los Angeles California 90024 —
AURORA Investigative Center Palo Alto California 94305 —
AURORA Investigative Center Thousand Oaks California 91360 —
AURORA Investigative Center Torrance California 90502 —
AURORA Investigative Center Aurora Colorado 80045 —
AURORA Investigative Center Denver Colorado 80218 —
AURORA Investigative Center New Haven Connecticut 06510 —
AURORA Investigative Center Clearwater Florida 33765 —
AURORA Investigative Center DeBary Florida 32713 —
AURORA Investigative Center Fort Lauderdale Florida 33309 —
AURORA Investigative Center Fort Myers Florida 33901 —
AURORA Investigative Center Miami Florida 33125 —
AURORA Investigative Center Orlando Florida 32810 —
AURORA Investigative Center Winter Park Florida 32789 —
AURORA Investigative Center Atlanta Georgia 30318 —
AURORA Investigative Center Columbus Georgia 31904 —
AURORA Investigative Center Lawrenceville Georgia 30046 —
AURORA Investigative Center Chicago Illinois 60637 —
AURORA Investigative Center Louisville Kentucky 40202 —
AURORA Investigative Center Baton Rouge Louisiana 70809 —
AURORA Investigative Center New Orleans Louisiana 70121 —
AURORA Investigative Center Boston Massachusetts 02118 —
AURORA Investigative Center Detroit Michigan 48201-2017 —
AURORA Investigative Center Grand Blanc Michigan 48439 —
AURORA Investigative Center Rochester Minnesota 55905 —
AURORA Investigative Center St Louis Missouri 63110 —
AURORA Investigative Center Las Vegas Nevada 89128 —
AURORA Investigative Center Newark New Jersey 07103 —
AURORA Investigative Center Great Neck New York 11021 —
AURORA Investigative Center New York New York 10016 —
AURORA Investigative Center New York New York 10021-4823 —
AURORA Investigative Center New York New York 11203 —
AURORA Investigative Center Syracuse New York 13210 —
AURORA Investigative Center Chapel Hill North Carolina 27514 —
AURORA Investigative Center Charlotte North Carolina 28204 —
AURORA Investigative Center Charlotte North Carolina 28210 —
AURORA Investigative Center Greenville North Carolina 27834 —
AURORA Investigative Center New Bern North Carolina 28562 —
AURORA Investigative Center Cleveland Ohio 44109 —
AURORA Investigative Center Columbus Ohio 43210 —
AURORA Investigative Center Oklahoma City Oklahoma 73103 —
AURORA Investigative Center Oklahoma City Oklahoma 73104 —
AURORA Investigative Center Charleston South Carolina 29425 —
AURORA Investigative Center Chattanooga Tennessee 37408 —
AURORA Investigative Center Hendersonville Tennessee 37075 —
AURORA Investigative Center Beaumont Texas 77036 —
AURORA Investigative Center Dallas Texas 75231 —
AURORA Investigative Center Dallas Texas 75246 —
AURORA Investigative Center Dallas Texas 75390 —
AURORA Investigative Center El Paso Texas 79905 —
AURORA Investigative Center El Paso Texas 79935 —
AURORA Investigative Center Houston Texas 77030 —
AURORA Investigative Center Arlington Virginia 22205 —
AURORA Richmond Virginia 23298 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 126 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03021499, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 27, 2023 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03021499 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →